OncoRes Medical


Contact Katharine Giles
Title CEO


Currently, surgeons rely on their senses of touch and sight and post-operative pathology to guide cancer surgery. In breast conserving surgery this approach results in ~30% of women needing more than one surgery to successfully remove all cancerous tissue.  Incomplete removal costs billions in repeat surgeries, creating a need for accurate, real-time technologies to provide intraoperative information.

OncoRes Medical has developed a novel imaging tool combining optical coherence tomography (OCT) and elastography for the real-time assessment of tissue micro-structure (OCME).  Our innovation has the potential to dramatically increase surgical accuracy by providing surgeons with a high resolution, handheld imaging probe to enable them to more effectively identify and  remove tumor during surgery. By identifying tumor that would have previously been missed, this technology can substantially improve patient outcomes in breast-conserving surgery. OCME is broadly applicable across organ-sparing surgery, minimally invasive and robotic surgery.

Company News

MedTech Innovator Announces OncoRes Medical as 2019 Value Award Winner at WSGR Device Conference

DateJun 24, 2019
Leading Startup Awarded $25,000 Global Prize for its Intraoperative Handheld Imaging Tools to Identify and More Effectively Remove Tumor in Patients with Breast Cancer